Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Dynamics of Viral and Host Immune Cell MicroRNA Expression during Acute Infectious Mononucleosis.

Kaul V, Weinberg KI, Boyd SD, Bernstein D, Esquivel CO, Martinez OM, Krams SM.

Front Microbiol. 2018 Jan 15;8:2666. doi: 10.3389/fmicb.2017.02666. eCollection 2017.

2.

Micro-RNAs in transplant tolerance.

Harden JT, Krams SM.

Curr Opin Organ Transplant. 2018 Feb;23(1):66-72. doi: 10.1097/MOT.0000000000000479.

PMID:
29064833
3.

Identifying specificity groups in the T cell receptor repertoire.

Glanville J, Huang H, Nau A, Hatton O, Wagar LE, Rubelt F, Ji X, Han A, Krams SM, Pettus C, Haas N, Arlehamn CSL, Sette A, Boyd SD, Scriba TJ, Martinez OM, Davis MM.

Nature. 2017 Jul 6;547(7661):94-98. doi: 10.1038/nature22976. Epub 2017 Jun 21.

4.

The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.

Martinez OM, Krams SM.

Transplantation. 2017 Sep;101(9):2009-2016. doi: 10.1097/TP.0000000000001767. Review.

PMID:
28376031
5.

NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein-Barr Virus.

Hatton O, Strauss-Albee DM, Zhao NQ, Haggadone MD, Pelpola JS, Krams SM, Martinez OM, Blish CA.

Front Immunol. 2016 Dec 15;7:607. doi: 10.3389/fimmu.2016.00607. eCollection 2016.

6.

Absence of miR-182 Augments Cardiac Allograft Survival.

Wei L, Kaul V, Qu X, Xiong X, Lau AH, Iwai N, Martinez OM, Krams SM.

Transplantation. 2017 Mar;101(3):524-530. doi: 10.1097/TP.0000000000001345.

7.

Applying Mass Cytometry to the Analysis of Lymphoid Populations in Transplantation.

Krams SM, Schaffert S, Lau AH, Martinez OM.

Am J Transplant. 2017 Aug;17(8):1992-1999. doi: 10.1111/ajt.14145. Epub 2016 Dec 23. Review.

PMID:
27888565
8.

Mass cytometry reveals a distinct immunoprofile of operational tolerance in pediatric liver transplantation.

Lau AH, Vitalone MJ, Haas K, Shawler T, Esquivel CO, Berquist WE, Martinez OM, Castillo RO, Krams SM.

Pediatr Transplant. 2016 Dec;20(8):1072-1080. doi: 10.1111/petr.12795. Epub 2016 Oct 26.

9.

Glycyrrhizin protects against focal cerebral ischemia via inhibition of T cell activity and HMGB1-mediated mechanisms.

Xiong X, Gu L, Wang Y, Luo Y, Zhang H, Lee J, Krams S, Zhu S, Zhao H.

J Neuroinflammation. 2016 Sep 8;13(1):241. doi: 10.1186/s12974-016-0705-5.

10.

Epstein-Barr virus-associated lymphoepithelial carcinoma after pediatric liver transplant.

Sang AX, Harris-Arnold A, Kambham N, Martinez OM, Krams SM, Strichartz D, Esquivel CO.

Liver Transpl. 2016 Jun;22(6):849-53. doi: 10.1002/lt.24457. No abstract available.

11.

Liver microRNA Profile of Induced Allograft Tolerance.

Vitalone MJ, Wei L, Fujiki M, Lau AH, Littau E, Esquivel C, Martinez OM, Krams SM.

Transplantation. 2016 Apr;100(4):781-90. doi: 10.1097/TP.0000000000001105.

12.

NKp46 Clusters at the Immune Synapse and Regulates NK Cell Polarization.

Hadad U, Thauland TJ, Martinez OM, Butte MJ, Porgador A, Krams SM.

Front Immunol. 2015 Sep 25;6:495. doi: 10.3389/fimmu.2015.00495. eCollection 2015.

13.

Epstein-Barr virus modulates host cell microRNA-194 to promote IL-10 production and B lymphoma cell survival.

Harris-Arnold A, Arnold CP, Schaffert S, Hatton O, Krams SM, Esquivel CO, Martinez OM.

Am J Transplant. 2015 Nov;15(11):2814-24. doi: 10.1111/ajt.13375. Epub 2015 Jul 3.

14.

MicroRNAs as master regulators of immune responses in transplant recipients.

Kaul V, Krams S.

Curr Opin Organ Transplant. 2015 Feb;20(1):29-36. doi: 10.1097/MOT.0000000000000148. Review.

PMID:
25563989
15.

The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease.

Hatton OL, Harris-Arnold A, Schaffert S, Krams SM, Martinez OM.

Immunol Res. 2014 May;58(2-3):268-76. doi: 10.1007/s12026-014-8496-1. Review.

16.

NK cells after transplantation: friend or foe.

Hadad U, Martinez O, Krams SM.

Immunol Res. 2014 May;58(2-3):259-67. doi: 10.1007/s12026-014-8493-4. Review.

PMID:
24522700
17.

Differential expression and functions of microRNAs in liver transplantation and potential use as non-invasive biomarkers.

Wei L, Gong X, Martinez OM, Krams SM.

Transpl Immunol. 2013 Dec;29(1-4):123-9. doi: 10.1016/j.trim.2013.08.005. Epub 2013 Aug 31. Review.

18.

Moderate hypothermia inhibits brain inflammation and attenuates stroke-induced immunodepression in rats.

Gu LJ, Xiong XX, Ito T, Lee J, Xu BH, Krams S, Steinberg GK, Zhao H.

CNS Neurosci Ther. 2014 Jan;20(1):67-75. doi: 10.1111/cns.12160. Epub 2013 Aug 24.

19.

PI3Kδ inhibition augments the efficacy of rapamycin in suppressing proliferation of Epstein-Barr virus (EBV)+ B cell lymphomas.

Furukawa S, Wei L, Krams SM, Esquivel CO, Martinez OM.

Am J Transplant. 2013 Aug;13(8):2035-43. doi: 10.1111/ajt.12328. Epub 2013 Jul 10.

20.

Encode: life, the universe, and everything.

Krams SM, Bromberg JS.

Ann Neurol. 2013 May;73(5):A8-9. doi: 10.1002/ana.23920. No abstract available.

PMID:
23749745
21.

Natural killer cell-activating receptor NKG2D mediates innate immune targeting of allogeneic neural progenitor cell grafts.

Phillips LK, Gould EA, Babu H, Krams SM, Palmer TD, Martinez OM.

Stem Cells. 2013 Sep;31(9):1829-39. doi: 10.1002/stem.1422.

22.

T cells contribute to stroke-induced lymphopenia in rats.

Gu L, Xiong X, Wei D, Gao X, Krams S, Zhao H.

PLoS One. 2013;8(3):e59602. doi: 10.1371/journal.pone.0059602. Epub 2013 Mar 15.

23.

Syk-induced phosphatidylinositol-3-kinase activation in Epstein-Barr virus posttransplant lymphoproliferative disorder.

Hatton O, Lambert SL, Phillips LK, Vaysberg M, Natkunam Y, Esquivel CO, Krams SM, Martinez OM.

Am J Transplant. 2013 Apr;13(4):883-890. doi: 10.1111/ajt.12137. Epub 2013 Feb 7.

24.

Literature watch: implications for transplantation.

Krams SM, Bromberg JS.

Am J Transplant. 2013 Feb;13(2):245. doi: 10.1111/ajt.12171. No abstract available.

25.

Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.

Hatton O, Lambert SL, Krams SM, Martinez OM.

PLoS One. 2012;7(8):e42610. doi: 10.1371/journal.pone.0042610. Epub 2012 Aug 3.

26.

Fetal T cells and immunological tolerance.

Krams SM, Bromberg JS.

Am J Transplant. 2012 Mar;12(3):511. doi: 10.1111/j.1600-6143.2012.04023.x. No abstract available.

27.

Changes in natural killer cell subsets in pediatric liver transplant recipients.

Pham B, Piard-Ruster K, Silva R, Gallo A, Esquivel CO, Martinez OM, Krams SM.

Pediatr Transplant. 2012 Mar;16(2):176-82. doi: 10.1111/j.1399-3046.2012.01653.x.

28.

Differential expression of microRNAs during allograft rejection.

Wei L, Wang M, Qu X, Mah A, Xiong X, Harris AG, Phillips LK, Martinez OM, Krams SM.

Am J Transplant. 2012 May;12(5):1113-23. doi: 10.1111/j.1600-6143.2011.03958.x. Epub 2012 Feb 2.

29.

Syk activation of phosphatidylinositol 3-kinase/Akt prevents HtrA2-dependent loss of X-linked inhibitor of apoptosis protein (XIAP) to promote survival of Epstein-Barr virus+ (EBV+) B cell lymphomas.

Hatton O, Phillips LK, Vaysberg M, Hurwich J, Krams SM, Martinez OM.

J Biol Chem. 2011 Oct 28;286(43):37368-78. doi: 10.1074/jbc.M111.255125. Epub 2011 Sep 9.

30.

The effect of MICA antigens on transplant outcomes: a systematic review.

Lu J, Luo L, Guo Y, Long D, Wei L, Shan J, Feng L, Li S, Yang X, Lu Y, Krams S, Li Y.

J Evid Based Med. 2011 May;4(2):106-21. doi: 10.1111/j.1756-5391.2011.01125.x. Review.

PMID:
23672701
31.

Toll-like receptor 4 contributes to small intestine allograft rejection.

Krams SM, Wang M, Castillo RO, Ito T, Phillips L, Higgins J, Kambham N, Esquivel CO, Martinez OM.

Transplantation. 2010 Dec 27;90(12):1272-7.

32.

Distinct roles for the NK cell-activating receptors in mediating interactions with dendritic cells and tumor cells.

Wai LE, Garcia JA, Martinez OM, Krams SM.

J Immunol. 2011 Jan 1;186(1):222-9. doi: 10.4049/jimmunol.1002597. Epub 2010 Nov 24.

33.

Acute rejection of small intestine allografts is associated with increased expression of toll-like receptors.

Castillo RO, Wang M, Ito T, Higgins J, Esquivel CO, Krams SM, Martinez OM.

Transplant Proc. 2010 Sep;42(7):2676-8. doi: 10.1016/j.transproceed.2010.05.157.

PMID:
20832568
34.

Identification of the rat NKG2D ligands, RAE1L and RRLT, and their role in allograft rejection.

Zhuo M, Fujiki M, Wang M, Piard-Ruster K, Wai LE, Wei L, Martinez OM, Krams SM.

Eur J Immunol. 2010 Jun;40(6):1748-57. doi: 10.1002/eji.200939779.

35.

MicroRNAs as immune regulators: implications for transplantation.

Harris A, Krams SM, Martinez OM.

Am J Transplant. 2010 Apr;10(4):713-9. doi: 10.1111/j.1600-6143.2010.03032.x. Epub 2010 Feb 25. Review.

36.

Induced tolerance to rat liver allografts involves the apoptosis of intragraft T cells and the generation of CD4(+)CD25(+)FoxP3(+) T regulatory cells.

Fujiki M, Esquivel CO, Martinez OM, Strober S, Uemoto S, Krams SM.

Liver Transpl. 2010 Feb;16(2):147-54. doi: 10.1002/lt.21963.

37.

Activation of the JAK/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma.

Vaysberg M, Lambert SL, Krams SM, Martinez OM.

Am J Transplant. 2009 Oct;9(10):2292-302. doi: 10.1111/j.1600-6143.2009.02781.x. Epub 2009 Jul 28.

38.

Epstein-Barr virus, rapamycin, and host immune responses.

Krams SM, Martinez OM.

Curr Opin Organ Transplant. 2008 Dec;13(6):563-8. doi: 10.1097/MOT.0b013e3283186ba9. Review.

39.

Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos.

Vaysberg M, Hatton O, Lambert SL, Snow AL, Wong B, Krams SM, Martinez OM.

J Biol Chem. 2008 Dec 26;283(52):36573-85. doi: 10.1074/jbc.M802968200. Epub 2008 Nov 5.

40.

Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients.

Stenard F, Nguyen C, Cox K, Kambham N, Umetsu DT, Krams SM, Esquivel CO, Martinez OM.

Pediatr Transplant. 2009 Feb;13(1):70-80. doi: 10.1111/j.1399-3046.2008.00917.x. Epub 2008 Mar 10.

PMID:
18331536
41.

Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.

Wai LE, Fujiki M, Takeda S, Martinez OM, Krams SM.

Transplantation. 2008 Jan 15;85(1):145-9. doi: 10.1097/01.tp.0000296817.28053.7b.

42.

Mutations to bid cleavage sites protect hepatocytes from apoptosis after ischemia/reperfusion injury.

Riddle-Taylor E, Nagasaki K, Lopez J, Esquivel CO, Martinez OM, Krams SM.

Transplantation. 2007 Sep 27;84(6):778-85.

43.

Rapamycin inhibits proliferation of Epstein-Barr virus-positive B-cell lymphomas through modulation of cell-cycle protein expression.

Vaysberg M, Balatoni CE, Nepomuceno RR, Krams SM, Martinez OM.

Transplantation. 2007 Apr 27;83(8):1114-21.

PMID:
17452903
44.

EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis.

Snow AL, Lambert SL, Natkunam Y, Esquivel CO, Krams SM, Martinez OM.

J Immunol. 2006 Sep 1;177(5):3283-93.

45.

NKp30 is a functional activation receptor on a subset of rat natural killer cells.

Hsieh CL, Nagasaki K, Martinez OM, Krams SM.

Eur J Immunol. 2006 Aug;36(8):2170-80.

46.

Reproduction and pregnancy in transplant recipients: current practices.

McKay DB, Adams PL, Bumgardner GL, Davis CL, Fine RN, Krams SM, Martinez OM, Murphy B, Pavlakis M, Tolkoff-Rubin N, Sherman MS, Josephson MA.

Prog Transplant. 2006 Jun;16(2):127-32.

PMID:
16789701
47.
48.

Keratins as susceptibility genes for end-stage liver disease.

Ku NO, Lim JK, Krams SM, Esquivel CO, Keeffe EB, Wright TL, Parry DA, Omary MB.

Gastroenterology. 2005 Sep;129(3):885-93.

PMID:
16143128
49.

IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses.

Obara H, Nagasaki K, Hsieh CL, Ogura Y, Esquivel CO, Martinez OM, Krams SM.

Am J Transplant. 2005 Sep;5(9):2094-103.

50.

Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation.

McKay DB, Josephson MA, Armenti VT, August P, Coscia LA, Davis CL, Davison JM, Easterling T, Friedman JE, Hou S, Karlix J, Lake KD, Lindheimer M, Matas AJ, Moritz MJ, Riely CA, Ross LF, Scott JR, Wagoner LE, Wrenshall L, Adams PL, Bumgardner GL, Fine RN, Goral S, Krams SM, Martinez OM, Tolkoff-Rubin N, Pavlakis M, Scantlebury V; Women's Health Committee of the American Society of Transplantation.

Am J Transplant. 2005 Jul;5(7):1592-9. Review.

Supplemental Content

Support Center